{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T18:59:47Z","timestamp":1789412387090,"version":"build-2803163510"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,2,17]],"date-time":"2021-02-17T00:00:00Z","timestamp":1613520000000},"content-version":"vor","delay-in-days":16,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006769","name":"Russian Science Foundation","doi-asserted-by":"publisher","award":["No 19-15-00145;"],"award-info":[{"award-number":["No 19-15-00145;"]}],"id":[{"id":"10.13039\/501100006769","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"crossref","award":["DFG, CRC128-B06"],"award-info":[{"award-number":["DFG, CRC128-B06"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100006604","name":"Bundesministerium f\u00fcr Bildung, Wissenschaft und Kultur","doi-asserted-by":"crossref","award":["CRC128-B06"],"award-info":[{"award-number":["CRC128-B06"]}],"id":[{"id":"10.13039\/501100006604","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2021,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Exact mechanisms of autoimmune disease development are still yet unknown. However, it is known that the development of autoimmune diseases is associated with defects in the immune system, namely, the violation of the bone marrow hematopoietic stem cells (HSCs) differentiation profiles. Different characteristics of autoimmune reaction development in experimental autoimmune encephalomyelitis (EAE) prone Th mice characterizing T-lymphocytes response were analyzed using standard approaches. Profiles of several HSCs differentiation of bone marrow (BFU-E, CFU-E, CFU-GM, CFU-GEMM, T- and B-lymphocytes) of Th male and female mice during spontaneous development of EAE were noticeably different. Patterns of total lymphocytes, B- and T-cells proliferation in several different organs (bone marrow, blood, spleen, thymus, and lymph nodes) were also remarkably different. In addition, there were in time noticeable differences in their changes for some organs of male and female mice. Characters of changes in the profiles of CD4 and CD8 cells proliferation in some organs not always coincide with those for total T lymphocytes. The changes in the differentiation profiles of HSCs and the level of lymphocytes proliferation in the bone marrow and other organs were associated with the increase in the concentration of antibodies against DNA, myelin basic protein, and myelin oligodendrocyte glycoprotein, and catalytic antibodies hydrolyzing these substrates. Despite some differences in changes in the analyzed parameters, in general, the spontaneous development of EAE in male and female mice occurs to some extent in a comparable way.<\/jats:p>","DOI":"10.1007\/s11033-020-06117-8","type":"journal-article","created":{"date-parts":[[2021,2,19]],"date-time":"2021-02-19T05:39:52Z","timestamp":1613713192000},"page":"1055-1068","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Catalytic antibodies in the bone marrow and other organs of Th mice during spontaneous development of experimental autoimmune encephalomyelitis associated with cell differentiation"],"prefix":"10.1007","volume":"48","author":[{"given":"Kseniya S.","family":"Aulova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrey E.","family":"Urusov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludmila B.","family":"Toporkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergey E.","family":"Sedykh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuliya A.","family":"Shevchenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valery P.","family":"Tereshchenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergei V.","family":"Sennikov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Budde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven G.","family":"Meuth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina A.","family":"Orlovskaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgy A.","family":"Nevinsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,17]]},"reference":[{"key":"6117_CR1","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1023\/A:1011064007686","volume":"21","author":"KC O\u2019Connor","year":"2001","unstructured":"O\u2019Connor KC, Bar-Or A, Hafler DA (2001) Neuroimmunology of multiple sclerosis. J Clin Immunol 21:81\u201392","journal-title":"J Clin Immunol"},{"key":"6117_CR2","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1002\/1531-8249(200006)47:6<694::AID-ANA2>3.0.CO;2-W","volume":"47","author":"JJ Archelos","year":"2000","unstructured":"Archelos JJ, Storch MK, Hartung HP (2000) The role of B cells and autoantibodies in multiple sclerosis. Ann Neurol 47:694\u2013706","journal-title":"Ann Neurol"},{"key":"6117_CR3","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/nrn784","volume":"3","author":"B Hemmer","year":"2002","unstructured":"Hemmer B, Archelos JJ, Hartung HP (2002) New concepts in the immunopathogenesis of multiple sclerosis. Nat Rev Neurosci 3:291\u2013301","journal-title":"Nat Rev Neurosci"},{"key":"6117_CR4","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1002\/1531-8249(200009)48:3<362::AID-ANA11>3.0.CO;2-6","volume":"48","author":"A Niehaus","year":"2000","unstructured":"Niehaus A, Shi J, Grzenkowski M et al (2000) Patients with active relapsing-remitting multiple sclerosis synthesize antibodies recognizing oligodendrocyte progenitor cell surface protein: implications for remyelination. Ann Neurol 48:362\u2013371","journal-title":"Ann Neurol"},{"key":"6117_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0165-5728(00)00409-4","volume":"112","author":"AH Cross","year":"2001","unstructured":"Cross AH, Trotter JL, Lyons J (2001) B cells and antibodies in CNS demyelinating disease. J Neuroimmunol 112:1\u201314","journal-title":"J Neuroimmunol"},{"key":"6117_CR6","doi-asserted-by":"publisher","first-page":"8341","DOI":"10.1073\/pnas.87.21.8341","volume":"87","author":"S Ikehara","year":"1990","unstructured":"Ikehara S, Kawamura M, Takao F (1990) Organ-specific and systemic autoimmune diseases originate from defects in hematopoietic stem cells. Proc Natl Acad Sci USA 87:8341\u20138344","journal-title":"Proc Natl Acad Sci USA"},{"key":"6117_CR7","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1111\/jcmm.12704","volume":"20","author":"VB Doronin","year":"2016","unstructured":"Doronin VB, Parkhomenko TA, Korablev A et al (2016) Changes in different parameters, lymphocyte proliferation and hematopoietic progenitor colony formation in EAE mice treated with myelin oligodendrocyte glycoprotein. J Cell Mol Med 20:81\u201394","journal-title":"J Cell Mol Med"},{"key":"6117_CR8","doi-asserted-by":"publisher","first-page":"3795","DOI":"10.1111\/jcmm.13289","volume":"21","author":"KS Aulova","year":"2017","unstructured":"Aulova KS, Toporkova LB, Lopatnikova JA et al (2017) Changes in haematopoietic progenitor colony differentiation and proliferation and the production of different abzymes in EAE mice treated with DNA. J Cell Mol Med 21:3795\u20133809","journal-title":"J Cell Mol Med"},{"key":"6117_CR9","first-page":"302","volume":"3","author":"VB Doronin","year":"2017","unstructured":"Doronin VB, Korablev A, Toporkova LB, Aulova KS et al (2017) Changes in several disease parameters including abzymes and hematopoietic progenitor colony formation in brain inflammation and demyelination. J Neurol Neurol Disord 3:302","journal-title":"J Neurol Neurol Disord"},{"key":"6117_CR10","doi-asserted-by":"publisher","first-page":"5816","DOI":"10.1111\/jcmm.13850","volume":"22","author":"KS Aulova","year":"2018","unstructured":"Aulova KS, Toporkova LB, Lopatnikova JA, Alshevskaya AA, Sedykh SE et al (2018) Changes in cell differentiation and proliferation lead to production of abzymes in EAE mice treated with DNA-Histone complexes. J Cell Mol Med 22:5816\u20135832","journal-title":"J Cell Mol Med"},{"key":"6117_CR11","doi-asserted-by":"publisher","first-page":"5089","DOI":"10.1016\/j.febslet.2006.08.036","volume":"580","author":"AA Andryushkova","year":"2006","unstructured":"Andryushkova AA, Kuznetsova IA, Orlovskaya IA et al (2006) Antibodies with amylase activity from the sera of autoimmune-prone MRL\/MpJ-lpr mice. FEBS Lett 580:5089\u20135095","journal-title":"FEBS Lett"},{"key":"6117_CR12","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1093\/intimm\/dxp060","volume":"21","author":"AS Andryushkova","year":"2009","unstructured":"Andryushkova AS, Kuznetsova IA, Orlovskaya IA et al (2009) Nucleotide- hydrolyzing antibodies from the sera of autoimmune-prone MRL-lpr\/lpr mice. Int immunol 21:935\u2013945","journal-title":"Int immunol"},{"key":"6117_CR13","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1111\/j.1582-4934.2007.00048.x","volume":"11","author":"AS Andryushkova","year":"2007","unstructured":"Andryushkova AS, Kuznetsova IA, Buneva VN et al (2007) Formation of different abzymes in autoimmune-prone MRL-lpr\/lpr mice is associated with changes in colony formation of haematopoetic progenitors. J Cell Mol Med 11:531\u2013551","journal-title":"J Cell Mol Med"},{"key":"6117_CR14","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1111\/j.1582-4934.2004.tb00325.x","volume":"8","author":"DI Polosukhina","year":"2004","unstructured":"Polosukhina DI, Kanyshkova TG, Doronin BM et al (2004) Hydrolysis of myelin basic protein by polyclonal catalytic IgGs from the sera of patients with multiple sclerosis. J Cell Mol Med 8:359\u2013368","journal-title":"J Cell Mol Med"},{"key":"6117_CR15","first-page":"BR266","volume":"11","author":"DI Polosukhina","year":"2005","unstructured":"Polosukhina DI, Buneva VN, Doronin BM et al (2005) Hydrolysis of myelin basic protein by IgM and IgA antibodies from the sera of patients with multiple sclerosis. Med Sci Monit 11:BR266\u2013BR272","journal-title":"Med Sci Monit"},{"key":"6117_CR16","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.imlet.2005.10.018","volume":"103","author":"DI Polosukhina","year":"2006","unstructured":"Polosukhina DI, Kanyshkova TG, Doronin BM et al (2006) Metal-dependent hydrolysis of myelin basic protein by IgGs from the sera of patients with multiple sclerosis. Immunol Lett 103:75\u201381","journal-title":"Immunol Lett"},{"key":"6117_CR17","first-page":"1239","volume":"63","author":"AG Baranovskii","year":"1998","unstructured":"Baranovskii AG, Kanyshkova TG, Mogelnitskii AS et al (1998) Polyclonal antibodies from blood and cerebrospinal fluid of patients with multiple sclerosis effectively hydrolyze DNA and RNA. Biochemistry (Mosc) 63:1239\u20131248","journal-title":"Biochemistry (Mosc)"},{"key":"6117_CR18","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/S0165-2478(01)00185-7","volume":"76","author":"AG Baranovskii","year":"2001","unstructured":"Baranovskii AG, Ershova NA, Buneva VN et al (2001) Catalytic heterogeneity of polyclonal DNA-hydrolyzing antibodies from the sera of patients with multiple sclerosis. Immunol Lett 76:163\u2013167","journal-title":"Immunol Lett"},{"key":"6117_CR19","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1002\/jmr.1143","volume":"24","author":"AM Bezuglova","year":"2011","unstructured":"Bezuglova AM, Konenkova LP, Doronin BM, Buneva VN, Nevinsky GA (2011) Affinity and catalytic heterogeneity and metal-dependence of polyclonal myelin basic protein-hydrolyzing IgGs from sera of patients with systemic lupus erythematosus. J Mol Recognit 24:960\u2013974","journal-title":"J Mol Recognit"},{"key":"6117_CR20","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1093\/intimm\/dxs071","volume":"24","author":"AM Bezuglova","year":"2012","unstructured":"Bezuglova AM, Konenkova LP, Buneva VN, Nevinsky GA (2012) IgGs containing light chains of the \u03bb-and \u03ba-type and of all subclasses (IgG1\u2013IgG4) from the sera of patients with systemic lupus erythematosus hydrolyze myelin. Int Immunol 24:759\u2013770","journal-title":"Int Immunol"},{"key":"6117_CR21","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/S0165-2478(02)00006-8","volume":"81","author":"OA Andrievskaya","year":"2002","unstructured":"Andrievskaya OA, Buneva VN, Baranovskii AG et al (2002) Catalytic diversity of polyclonal RNA-hydrolyzing IgG antibodies from the sera of patients with systemic lupus erythematosus. Immunol Lett 81:91\u2013198","journal-title":"Immunol Lett"},{"key":"6117_CR22","doi-asserted-by":"publisher","first-page":"e93001","DOI":"10.1371\/journal.pone.0093001","volume":"9","author":"TA Parkhomenko","year":"2014","unstructured":"Parkhomenko TA, Doronin VB, Castellazzi M et al (2014) Comparison of DNA-hydrolyzing antibodies from the cerebrospinal fluid and serum of patients with multiple sclerosis. PLoS ONE 9:e93001","journal-title":"PLoS ONE"},{"key":"6117_CR23","doi-asserted-by":"publisher","first-page":"e107807","DOI":"10.1371\/journal.pone.0107807","volume":"9","author":"VB Doronin","year":"2014","unstructured":"Doronin VB, Parkhomenko TA, Castellazzi M et al (2014) Comparison of antibodies hydrolyzing myelin basic protein from the cerebrospinal fluid and serum of patients with multiple sclerosis. PLoS ONE 9:e107807","journal-title":"PLoS ONE"},{"key":"6117_CR24","doi-asserted-by":"publisher","first-page":"e0154688","DOI":"10.1371\/journal.pone.0154688","volume":"11","author":"VB Doronin","year":"2016","unstructured":"Doronin VB, Parkhomenko TA, Castellazzi M et al (2016) Comparison of antibodies with amylase activity from cerebrospinal fluid and serum of patients with multiple sclerosis. PLoS ONE 11:e0154688","journal-title":"PLoS ONE"},{"key":"6117_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/3527603662.ch1","volume-title":"Catalytic antibodies","year":"2005","unstructured":"Keinan EE (ed) (2005) Catalytic antibodies. Wiley, Weinheim, pp 1\u2013586"},{"key":"6117_CR26","first-page":"100","volume-title":"Multiple sclerosis","author":"GA Nevinsky","year":"2016","unstructured":"Nevinsky GA (2016) Autoimmune processes in multiple sclerosis: Production of harmful catalytic antibodies associated with significant changes in the hematopoietic stem cell differentiation and proliferation. In: Conzalez-Quevedo A (ed) Multiple sclerosis. InTech, Rijeka, pp 100\u2013147"},{"key":"6117_CR27","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1002\/3527603662.ch19","volume-title":"Catalytic antibodies","author":"GA Nevinsky","year":"2005","unstructured":"Nevinsky GA, Buneva VN (2005) Natural catalytic antibodies-abzymes. In: Keinan E (ed) Catalytic antibodies. Wiley, Weinheim, pp 505\u2013569"},{"key":"6117_CR28","first-page":"1","volume-title":"Autoimmune diseases: symptoms, diagnosis and treatment","author":"GA Nevinsky","year":"2010","unstructured":"Nevinsky GA (2010) Natural catalytic antibodies in norm and in autoimmune diseases. In: Brenner KJ (ed) Autoimmune diseases: symptoms, diagnosis and treatment. Nova Science Publishers Inc, New York, pp 1\u2013107"},{"key":"6117_CR29","first-page":"151","volume-title":"Understanding HIV\/AIDS management and care \u2013 pandemic approaches the 21st century","author":"GA Nevinsky","year":"2011","unstructured":"Nevinsky GA (2011) Natural catalytic antibodies in norm and in HIV-infected patients. In: Kasenga FH (ed) Understanding HIV\/AIDS management and care \u2013 pandemic approaches the 21st century. InTech, Rijeka, pp 151\u2013192"},{"key":"6117_CR30","first-page":"41","volume-title":"Lupus","author":"GA Nevinsky","year":"2017","unstructured":"Nevinsky GA (2017) Catalytic antibodies in norm and systemic lupus erythematosus. In: Khan WA (ed) Lupus. InTech, Rijeka, pp 41\u2013101"},{"key":"6117_CR31","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.bbadis.2010.06.010","volume":"1812","author":"AL Croxford","year":"2011","unstructured":"Croxford AL, Kurschus FC, Waisman A (2011) Mouse models for multiple sclerosis: historical facts and future implications. Biochim Biophys Acta 1812:177\u2013183","journal-title":"Biochim Biophys Acta"},{"key":"6117_CR32","first-page":"1","volume":"15","author":"SD Miller","year":"2007","unstructured":"Miller SD, Karpus WJ, Davidson TS (2007) Experimental A. Autoimmune encephalomyelitis in the mouse. Curr Protoc Immunol 15:1","journal-title":"Curr Protoc Immunol"},{"key":"6117_CR33","unstructured":"Mouse EAE models. Overview and Model Selection Hooke Laboratories, Inc; 2011\u20132013."},{"key":"6117_CR34","doi-asserted-by":"publisher","first-page":"E6182","DOI":"10.1073\/pnas.1601350113","volume":"113","author":"L Klotz","year":"2016","unstructured":"Klotz L, Kuzmanov I, Hucke S, Gross CC, Posevitz V, Dreykluft A, Schulte-Mecklenbeck A, Janoschka C et al (2016) B7\u2013H1 shapes T-cell-mediated brain endothelial cell dysfunction and regional encephalitogenicity in spontaneous CNS autoimmunity. Proc Natl Acad Sci USA 113:E6182\u2013E6191","journal-title":"Proc Natl Acad Sci USA"},{"key":"6117_CR35","volume-title":"Janeway's Immunobiology","author":"M Kenneth","year":"2012","unstructured":"Kenneth M (2012) Janeway\u2019s Immunobiology, 8th edn. Garland Science, New York","edition":"8"},{"key":"6117_CR36","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1385\/ABAB:83:1-3:85","volume":"83","author":"H Sinohara","year":"2000","unstructured":"Sinohara H, Matsuura K (2000) Does catalytic activity of Bence-Jones proteins contribute to the pathogenesis of multiple myeloma? Appl Biochem Biotechnol 83:85\u201392","journal-title":"Appl Biochem Biotechnol"},{"key":"6117_CR37","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/BF02787708","volume":"75","author":"AV Kozyr","year":"1998","unstructured":"Kozyr AV, Kolesnikov AV, Aleksandrova ES et al (1998) Autoantibodies to nuclear antigens, correlation between cytotoxicity and DNA-hydrolyzing activity. Appl Biochem Biotechnol 75:45\u201361","journal-title":"Appl Biochem Biotechnol"},{"key":"6117_CR38","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1111\/j.1582-4934.2003.tb00227.x","volume":"7","author":"GA Nevinsky","year":"2003","unstructured":"Nevinsky GA, Buneva VN (2003) Catalytic antibodies in healthy humans and patients with autoimmune and viral pathologies. J Cell Mol Med 7:265\u2013276","journal-title":"J Cell Mol Med"},{"key":"6117_CR39","first-page":"513","volume":"153","author":"S Founel","year":"2002","unstructured":"Founel S, Muller S (2002) Antinucleosome antibodies and T-cell response in systemic lupus erythematosus. Ann Med Interne (Paris) 153:513\u2013519","journal-title":"Ann Med Interne (Paris)"},{"key":"6117_CR40","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1073\/pnas.98.4.1793","volume":"98","author":"RA Williamson","year":"2001","unstructured":"Williamson RA, Burgoon MP, Owens GP et al (2001) Anti-DNA antibodies are a major component of the intrathecal B cell response in multiple sclerosis. Proc Natl Acad Sci USA 98:1793\u20131798","journal-title":"Proc Natl Acad Sci USA"},{"key":"6117_CR41","first-page":"727","volume":"29","author":"AN Boiko","year":"1995","unstructured":"Boiko AN, Favorova OO (1995) Multiple sclerosis: molecular and cellular mechanisms. Mol Biol (Mosk) 29:727\u2013749","journal-title":"Mol Biol (Mosk)"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-020-06117-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11033-020-06117-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-020-06117-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,2]],"date-time":"2021-03-02T16:35:05Z","timestamp":1614702905000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11033-020-06117-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["6117"],"URL":"https:\/\/doi.org\/10.1007\/s11033-020-06117-8","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"14 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare the absence of competing for financial interests and none of the authors have any non-financial conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All experiments with mice were carried out pursuant to protocols of the Bioethical Committee of the Institute of Cytology and Genetics (document number 134A of 07 September, 2010) corresponding to humane principles of work with animals of the European Communities Council Directive 86\/609\/CEE. The Bioethical ICG committee supported our study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human and\/or animals rights"}}]}}